Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Clin Res Hepatol Gastroenterol ; 48(7): 102412, 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38964606

ABSTRACT

BACKGROUND: In recent times, sarcopenia and non-alcoholic fatty liver disease (NAFLD) have garnered widespread attention in public health. Nevertheless, the relationship between sarcopenia and NAFLD remains uncertain. This study investigated the association between NAFLD and sarcopenia in the elderly population. METHODS: In this cross-sectional study, 1099 adults aged 60 and older participated. The participants were classified based on their body composition, and the International Society of Physical and Rehabilitation Medicine's diagnostic algorithm (ISarcoPRM) was utilized to diagnose sarcopenia, while the fatty liver index was utilized to diagnose NAFLD. Binary logistic regression analysis determined the correlation between NAFLD and sarcopenia. RESULTS: Of the 1099 participants, 213 (58.2 %) males and 480 (65.5 %) females were afflicted with NAFLD. After adjusting for other clinical factors, exercise was found to decrease the likelihood of NAFLD in females (but not in males) by approximately 70 % [relative risk (RR): 0.312, 95 % confidence interval (CI): 0.182-0.547]. In addition, sarcopenia was not discerned as a risk factor for NAFLD in either gender (both p > 0.05). However, obesity increased the likelihood of NAFLD in males by 27.5 (95 % CI: 10.4-73.1) and in females by 28.1 (95 % CI: 17.1-46.4), and sarcopenic obesity increased the likelihood of NAFLD by 49.5 (95 % CI: 11.1-219.1) in males and 35.5 (95 % CI: 18.5-68.2) in females (all p < 0.001). CONCLUSION: Our study suggests that sarcopenia is not a risk factor for NAFLD in non-obese elderly subjects. However, a strong association was observed between obesity, especially sarcopenic obesity, and NAFLD. Regular physical activity seems protective for NAFLD in older females.

2.
Rev Esp Enferm Dig ; 113(7): 490-493, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33233910

ABSTRACT

AIM: Helicobacter pylori (H. pylori) eradication is still an important issue in countries with high antibiotic resistance. This study aimed to compare the efficacy and safety of two bismuth-containing treatment modalities in H. pylori treatment in Turkey. MATERIAL AND METHODS: subjects with H. pylori infection who were treated with either bismuth-containing quadruple therapy (pantoprazole 40 mg bid, tetracycline 500 mg qid, metronidazole 500 mg tid, bismuth subcitrate 262 mg qid daily) (BQT group) or modified quadruple therapy (pantoprazole 40 mg bid, amoxicillin 1 g bid, metronidazole 500 mg tid, bismuth subcitrate 262 mg qid daily) (MBQT group) for 14 days were compared, retrospectively. The eradication success rate, adverse events related to the medications and compliance were investigated. RESULTS: a total of 128 patients in the BQT group and 102 patients in the MBQT group completed the treatment. The overall rate of adverse events was significantly higher in the BQT group compared with the MBQT group (39.4 % vs 18.6; p: 0.001). Among the adverse events, nausea-vomiting and abdominal discomfort was significantly more frequent in the BQT group than in the MBQT group (p: 0.001). The adverse events were mild-moderate in both groups and life threatening adverse events were not present in any of the patients. CONCLUSION: although both regimens were highly effective and safe in H. pylori eradication, both intention-to-treat (ITT) and per-protocol (PP) eradication rates were higher and adverse events were lower in the modified quadruple therapy group. Modified quadruple therapy should be kept in mind for the first-line treatment of H. pylori in regions with high clarithromycin and metronidazole resistance.


Subject(s)
Helicobacter Infections , Helicobacter pylori , Anti-Bacterial Agents/therapeutic use , Bismuth/therapeutic use , Drug Therapy, Combination , Helicobacter Infections/drug therapy , Humans , Metronidazole/therapeutic use , Retrospective Studies , Tetracycline/therapeutic use , Treatment Outcome , Turkey
3.
J Hazard Mater ; 345: 27-37, 2018 Mar 05.
Article in English | MEDLINE | ID: mdl-29128724

ABSTRACT

In this work, iodine (I) doped hollow and mesoporous Fe2O3 photocatalyst particles were fabricated for the first time through sol-gel method. Phase structure, surface morphology, particle size, specific surface area and optical band gap of the synthesized Fe2O3 photocatalysts were analyzed by X-ray diffraction (XRD), field emission scanning electron microscope (FESEM), X-ray photoelectron spectroscopy (XPS), BET surface analysis, particle size analyzer and UV-vis diffuse reflectance spectrum (UV-vis DRS), respectively. Also, electrochemical properties and photoluminescence spectra of Fe2O3 particles were measured. The results illustrated that high crystalline, hollow and mesoporous Fe2O3 particles were formed. The optical band gap values of the Fe2O3 photocatalysts changed between 2.104 and 1.93eV. Photocatalytic efficiency of Fe2O3 photocatalysts were assessed via MB solution. The photocatalytic activity results exhibited that I doping enhanced the photocatalytic efficiency. 1% mole iodine doped (I-2) Fe2O3 photocatalyst had 97.723% photodegradation rate and 8.638×10-2min-1 kinetic constant which showed the highest photocatalytic activity within 45min. Moreover, stability and reusability experiments of Fe2O3 photocatalysts were carried out. The Fe2O3 photocatalysts showed outstanding stability after four sequence tests. As a result, I doped Fe2O3 is a good candidate for photocatalysts.

4.
Article in English | MEDLINE | ID: mdl-29201732

ABSTRACT

Hepatocellular carcinoma (HCC) is the most common malignant tumor of the liver. Hepatitis B virus infection is one of the most important etilogical factors of HCC. In this case report, a patient with HCC previously infected and having ongoing immunity against hepatitis B virus will be discussed. HOW TO CITE THIS ARTICLE: Ates I, Kaplan M, Demirci S, Altiparmak E. A Hepatocellular Carcinoma Case in a Patient Who had Immunity to Hepatitis B Virus Earlier. Euroasian J Hepato-Gastroenterol 2016;6(1):82-83.

6.
Blood Coagul Fibrinolysis ; 24(3): 243-6, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23425662

ABSTRACT

Vascular thrombosis and systemic hypercoagulable states are known complications of pancreatitis. Higher levels of mean platelet volume (MPV) have been associated with thrombotic diseases. However, a few studies have investigated the association between acute pancreatitis and MPV. We aimed to investigate whether there is a difference of MPV and coagulation parameters in patients with active and remission in acute pancreatitis. We included 24 consecutive patients with biliary acute pancreatitis and 24 consecutive healthy age-matched and sex-matched controls. Full blood counts and other laboratory tests were collected at onset and remission. The MPV was significantly higher in patients with acute pancreatitis at admission 8.6±1.4 fl than controls 7.6±0.7 fl (P=0.005). We detected positive correlation between, aspartate aminotransferase, alanine aminotransferase, γ-glutamyltransferase, amylase, lipase, and glucose, BMI, D-dimer and MPV. However, there was negative correlation between progression, thrombocyte counts, hemoglobin and MPV. As a result higher MPV levels in acute pancreatitis may reflect hypercoagulation associated with pancreatitis.


Subject(s)
Blood Platelets/metabolism , Pancreatitis/blood , Acute Disease , Adult , Biomarkers/blood , Blood Coagulation , Blood Platelets/pathology , Body Mass Index , Case-Control Studies , Erythrocyte Indices , Female , Humans , Male , Middle Aged , Pancreatitis/pathology , Platelet Activation , Platelet Count
7.
Ann Nutr Metab ; 61(4): 271-4, 2012.
Article in English | MEDLINE | ID: mdl-23208155

ABSTRACT

OBJECTIVES: Obesity markedly increases the risk of severe acute pancreatitis (AP). Several adipokines have been ascribed a role as a predictor of clinical severity in AP. Therefore, the aim of this study was to investigate a possible relationship between leptin and adiponectin and mild biliary AP. METHODS: We included 24 consecutive patients with mild biliary AP and 24 consecutive healthy age- and sex-matched controls. Clinical severity was classified by the Ranson score. ELISA was used to assess leptin and adiponectin levels on admission and in remission. Complete blood cell counts and other laboratory tests were also performed at baseline and in remission. RESULTS: Leptin, adiponectin, insulin and HOMA-IR measurements showed no difference in pancreatitis patients both on admission and in remission compared to the control group. No difference was found in leptin, insulin or HOMA-IR levels in the course of pancreatitis. However, adiponectin levels were higher in remission compared to admission. CONCLUSIONS: Increased adiponectin levels in remission may be an indication of improvement in this condition. Further studies are needed to determine whether adiponectin provides protection from AP.


Subject(s)
Adiponectin/blood , Pancreatitis/blood , Pancreatitis/physiopathology , Acute Disease , Adult , Aged , Body Mass Index , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Insulin/blood , Insulin Resistance , Leptin/blood , Male , Middle Aged , Obesity/blood , Obesity/complications , Obesity/physiopathology , Pancreatitis/etiology
8.
Scand J Clin Lab Invest ; 72(3): 192-6, 2012 May.
Article in English | MEDLINE | ID: mdl-22356682

ABSTRACT

BACKGROUND AND AIM: Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) is a member of the tumor necrosis factor super family of structurally-related cytokines. The aim of this study was to determine the diagnostic and prognostic role of serum TWEAK concentration in patients with acute pancreatitis. METHODS: Twenty four patients with acute pancreatitis and 24 consecutive healthy age- and sex-matched control subjects were included in the study. The serum concentrations of TWEAK were measured at admission and then at remission. The average time between admission and remission was 7-10 days. RESULTS: At admission, TWEAK concentration was significantly lower in patients with acute pancreatitis compared to control subjects (p < 0.001). Serum TWEAK concentrations were elevated after the remission period, however the differences were not statistically significant. In addition, serum TWEAK concentration showed a significant, inverse correlation with amylase, lipase, CRP, AST, fibrinogen, LDH and a positive correlation with calcium, albumin and platelet count. CONCLUSIONS: Patients with acute pancreatitis have lower serum TWEAK concentration than healthy subjects. These results suggest that serum TWEAK concentration could be a potential biomarker of acute pancreatitis.


Subject(s)
Biomarkers/blood , Pancreatitis/blood , Tumor Necrosis Factors/blood , Acute Disease , Adult , Aged , Amylases/blood , Apoptosis , C-Reactive Protein/analysis , Cytokine TWEAK , Female , Humans , Ligands , Lipase/blood , Male , Middle Aged , Pancreatitis/diagnosis
9.
South Med J ; 102(9): 972-3, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19668026

ABSTRACT

Polyarteritis nodosa (PAN) is a necrotizing vasculitis and may affect multiple organ systems. Due to the rupture of microaneurysms, perirenal hematomas may occur in both kidneys. Spontaneous perirenal hematoma is an infrequent complication of isolated PAN. Also, involvement of the splenic arteries is a rare occurrence in polyarteritis nodosa. Perirenal hematoma rupture is a serious clinical condition. Patients with life-threatening visceral bleeding must be treated with a selective embolization procedure or radical surgery because nonoperative management has been associated with a significant mortality rate.


Subject(s)
Hematoma/complications , Kidney Diseases/complications , Polyarteritis Nodosa/complications , Polyarteritis Nodosa/diagnosis , Splenic Infarction/complications , Angiography , Fatal Outcome , Female , Hematoma/diagnostic imaging , Humans , Kidney Diseases/diagnostic imaging , Middle Aged , Splenic Infarction/diagnostic imaging , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...